HBK Investments L P trimmed its holdings in Humana Inc (NYSE:HUM) by 40.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 165,000 shares of the insurance provider’s stock after selling 113,892 shares during the quarter. Humana comprises about 0.4% of HBK Investments L P’s investment portfolio, making the stock its 19th biggest holding. HBK Investments L P owned about 0.12% of Humana worth $40,932,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of HUM. Nationwide Fund Advisors increased its stake in shares of Humana by 0.4% in the 3rd quarter. Nationwide Fund Advisors now owns 170,587 shares of the insurance provider’s stock worth $41,560,000 after acquiring an additional 758 shares in the last quarter. Raymond James Financial Services Advisors Inc. increased its stake in shares of Humana by 68.0% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 4,724 shares of the insurance provider’s stock worth $1,151,000 after acquiring an additional 1,912 shares in the last quarter. Gamco Investors INC. ET AL increased its stake in shares of Humana by 71.5% in the 3rd quarter. Gamco Investors INC. ET AL now owns 8,875 shares of the insurance provider’s stock worth $2,162,000 after acquiring an additional 3,700 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of Humana by 10.5% in the 3rd quarter. Principal Financial Group Inc. now owns 386,776 shares of the insurance provider’s stock worth $94,230,000 after acquiring an additional 36,899 shares in the last quarter. Finally, HL Financial Services LLC increased its stake in shares of Humana by 37.8% in the 3rd quarter. HL Financial Services LLC now owns 10,975 shares of the insurance provider’s stock worth $2,674,000 after acquiring an additional 3,012 shares in the last quarter. Institutional investors own 97.85% of the company’s stock.
In other news, CEO Bruce D. Broussard sold 14,075 shares of Humana stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $274.32, for a total value of $3,861,054.00. Following the completion of the sale, the chief executive officer now directly owns 113,896 shares in the company, valued at $31,243,950.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian P. Leclaire sold 1,679 shares of Humana stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the sale, the senior vice president now owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The disclosure for this sale can be found here. Insiders sold 40,579 shares of company stock valued at $10,842,942 over the last quarter. Company insiders own 0.60% of the company’s stock.
Shares of Humana Inc (HUM) opened at $272.50 on Monday. Humana Inc has a 12 month low of $203.48 and a 12 month high of $293.35. The company has a market cap of $37,518.98, a P/E ratio of 16.34, a PEG ratio of 1.48 and a beta of 0.95. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.48.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The firm had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. During the same period in the previous year, the business posted $2.34 earnings per share. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. research analysts anticipate that Humana Inc will post 13.81 EPS for the current fiscal year.
Humana announced that its Board of Directors has approved a share repurchase program on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.73%. Humana’s payout ratio is currently 9.59%.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/12/humana-inc-hum-shares-sold-by-hbk-investments-l-p.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.